| Report ID |
16553 |
| Drug Identification Number |
02230578 |
| Brand name |
TWINRIX |
| Common or Proper name |
Combined hepatitis A (inactivated) and hepatitis B (recombinant) vaccine |
| Company Name |
GLAXOSMITHKLINE INC |
| Market Status |
MARKETED |
| Active Ingredient(s) |
HEPATITIS A VACCINE, INACTIVATED
HEPATITIS B SURFACE ANTIGEN |
| Strength(s) |
720UNIT
20MCG |
| Dosage form(s) |
SUSPENSION |
| Route of administration |
INTRAMUSCULAR |
| Packaging size |
1's |
| ATC code |
J07BC |
| ATC description |
VIRAL VACCINES |
| Reason for shortage |
Delay in shipping of the drug. |
| Anticipated start date |
|
| Actual start date |
2017-07-18 |
| Estimated end date |
2017-12-07 |
| Actual end date |
2017-12-04 |
| Shortage status |
Resolved |
| Updated date |
2017-12-06 |
| Company comments |
Supply released July 10, 2017, August 9, 2017, October 3, 2017, and October 20, 2017 with limited quantity. Supply disruptions may be seen in the private market. Product under allocation. |
| Health Canada comments |
|
| Tier 3 Status |
No |
| Company contact information |
1-800-387-7374 |
